Cardiovascular Disease

Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself.

What is Cardiovascular Disease?

Diseases of disorders of this system are termed cardiovascular diseases. Cardiovascular diseases kill an estimated 17 million people worldwide each year. Majority of these are due to heart attacks and strokes.

Cardiovascular Disease Diagnosis

Cardiovascular Disease Research

Lowering Risk for Cardiovascular Disease

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Cardiovascular Drugs

Cardiovascular Benefits of Blueberries

Non-Communicable Diseases

What is Microvascular Endothelial Dysfunction?

Latest Cardiovascular Disease News and Research

Life's Essential 8: key to reducing heart disease and mortality through epigenetics

Whether DNA methylation-based epigenetic age biomarkers mediate the associations between LE8 score and risks of CVD, CVD-specific mortality, and all-cause mortality.

31 May 2024

Is there an association between fatherhood and cardiovascular outcomes?

Associations between fatherhood and cardiovascular health (CVH), disease (CVD), and mortality.

31 May 2024

COVID-19 associated with higher risk of erectile dysfunction

Men previously diagnosed with COVID-19 are at a greater risk of developing new-onset erectile dysfunction.

31 May 2024

RNA interference agent plozasiran targets APOC3 for effective mixed hyperlipidemia treatment

Researchers evaluate the efficacy of plazosiran treatment on fasting triglyceride levels in adult patients with mixed hyperlipidemia.

31 May 2024

Heart-healthy habits keep you biologically young, study shows

A new study in the Journal of the American Heart Association reveals that heart-healthy lifestyle factors are linked to younger biological age and lower cardiovascular disease risk through DNA methylation.

29 May 2024

RNA-based therapy shows promise in reducing cholesterol and triglycerides

A small interfering RNA (siRNA) investigational therapy that inhibits a gene involved in lipoprotein metabolism has been shown in a clinical trial led by Mount Sinai researchers to significantly reduce levels of different types of cholesterol and triglycerides in individuals with mixed hyperlipidemia, a condition in which fats build up in the blood.

29 May 2024

Heart healthy behaviors may slow biological aging, research shows

The benefit of better heart health may be associated with the positive impact of heart healthy lifestyle factors on biological aging (the age of the body and its cells), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

29 May 2024

The prediabetes paradox: Balancing early intervention and overdiagnosis

Prediabetes, a diagnosis intended to identify high-risk persons and prevent progression to diabetes, has been a topic of ongoing debate, and experts continue to disagree about its screening criteria, interpretation, and implications.

28 May 2024

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

A recent study in Nature Medicine shows semaglutide reduces kidney risks in non-diabetic obese patients with cardiovascular disease by 22%. The SELECT trial results highlight semaglutide's benefits for kidney function and overall cardiovascular health.

28 May 2024

Exercise pattern study reveals lower Parkinson's risk for weekend warriors and regulars alike

A recent study in npj Digital Medicine found that both "weekend warrior" and regular exercise patterns significantly reduce Parkinson's disease (PD) risk. The findings suggest exercise duration is more critical than frequency in mitigating PD risk.

28 May 2024

Research reveals loneliness as a complex interplay of social impairments, oxytocin, and illness

A recent review in the journal Neuroscience & Biobehavioral Reviews presents a multidimensional model of loneliness, exploring its impact on social interactions, the oxytocin system, and illness. The study emphasizes the need for multidisciplinary collaboration to understand and address loneliness effectively.

28 May 2024

New national program aims to address loneliness among adolescents

Social prescriptions for activities such as gardening, fishing, attending museums, as well arts & sports clubs are to be offered to children and adolescents who report high levels of loneliness or low community connection as part of a new four-year project led by UCL researchers.

28 May 2024

Taking semaglutide once weekly may lower the chances of kidney disease, says study

The effects of semaglutide (administered once weekly) on the outcomes of kidney disease.

28 May 2024

Heavy menstrual bleeding raises heart disease risk in young women

Study found that heavy menstrual bleeding (HMB) is linked to increased cardiovascular disease (CVD) risk in young women, even without irregular menstruation.

28 May 2024

AI could offer companionship to lonely people

Artificial Intelligence (AI) technology could offer companionship to lonely people amid an international epidemic of loneliness, says a robotics expert.

27 May 2024

Mediterranean diet cuts environmental impact and improves metabolic health, study finds

Researchers found that a Mediterranean diet with reduced energy intake significantly reduced environmental impacts, such as acidification, eutrophication, and land use, in individuals with metabolic syndrome. Caloric reduction and diet adherence were key factors mediating these benefits.

27 May 2024

Ketogenic diet improves metabolic and mental health in schizophrenia and bipolar disorder patients, study finds

Researchers found that a ketogenic diet significantly improves both metabolic and psychiatric health in individuals with schizophrenia or bipolar disorder, with notable reductions in weight, waist circumference, and mental illness severity.

27 May 2024

Increased risk of erectile dysfunction with semaglutide in non-diabetic obese patients

Researchers found that semaglutide treatment for weight loss in non-diabetic, obese men is associated with an increased risk of erectile dysfunction and testosterone deficiency.

26 May 2024

SELECT trial shows semaglutide reduces kidney decline in obese patients

The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular disease but without diabetes.

25 May 2024

Cherries and berries: Nature’s sweet remedy for a healthy heart

Research paper reviews the cardiovascular benefits of phenolic compounds in cherries and berries, highlighting their potential to reduce inflammation, oxidative stress, and improve lipid profiles. Regular consumption of these fruits can significantly lower the risk of cardiovascular diseases.

23 May 2024